Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-17 and IL-23 antagonists and methods of using the same

IL-17 and IL-23 antagonists and methods of using the same

US Patent 7790862 · Granted Sep 7, 2010

Estimated economic value: $3,304,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multispecific antibody analogs comprising a common light chain, and methods of t2024
Tissue-homing peptide conjugates and methods of use thereof2024
Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and me2024
Pelvic leveler2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Tissue-homing peptide conjugates and methods of use thereof2023
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors2022
Methods of treatment using IL-23p19 monoclonal antibodies2022
Cartilage-homing peptide conjugates and methods of use thereof2021
Materials and methods for producing animals with short hair2020
Use of IL-17A and IL-17F cross-reactive monoclonal antibodies for treating infla2020